Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of extracting metals specifically, quickly and in a controlled manner. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: Startup Activities: nanotech biotech deeptech healthtech Technologies: Synthetic Biology | 12 | 2 | 3 | 13 | |
ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 10 | |
LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 7 | 7 | 1 | 11 | |
Cellenion Experts in single cell isolation technology for sequencing and cell line development applications. Cellenion offers solutions and technologies for controlled cell dispensing with applications in the fields of single-cell isolation and bioprinting : Ability to manipulate single-cell has long been a challenge for the scientific community due to their micrometric size and delicate nature. Cellenion has developed and patented CellenONE, a breakthrough single cell isolation and dispensing technology. CellenONE provides outstanding single cell precision, high throughput, and unmatched recovery. Bioprinting is the process of generating spatially-controlled cell patterns using 3D printing technologies. Cellenion will aim toward both miniaturization and automation … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 25 | |
BIOMNIGENE Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 2 | 7 | |
Exeliom Biosciences Crossing the next frontier, to give you a fair chance to fight Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies in immuno-oncology and immuno-inflammation. Our novel candidates harness microbiome-associated innate immune regulatory mechanisms. Inflammatory Bowel Diseases, Live Biotherapeutics, Microbiome, Immunotherapies, Immuno-oncology, and Immuno-inflammation Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 4 | 9 | 8 | |
ANTINEO Antineo aims to accompany customers in the preclinical development of novel anticancer agents. We provide services and strategic advice for preclinical development, optimal choice of in vitro and in vivo models as well as strategic input on potential indications to target in the therapeutic landscape. Développement préclinique, in vitro, ex vivo, in vivo, Preuve de concept, Expertise scientifique en pharmacologie, and Modèles à façon Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 1 | 4 | 12 | |
Kejako Keep your Eyes Young Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 2 | 4 | 6 | |
NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 30 | 10 | 25 | 38 | |
Fabentech Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields … Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 17 | 4 | 13 | 51 | |
FasTeesH [Automatic translation follows] HesY, a medical device for effective dental brushing in 10 seconds for healthcare and accommodation establishments 📢📢📢Our consumer product, Y-Brush, is available now: http://ow.ly/DMal30luqQK 🚀🚀🚀 FasTeesH is a Lyon startup developing a "toothbrush of the future" that cleans all teeth simultaneously, simply and effectively, in just 10 seconds. Why? Few people like brushing their teeth. This daily task is therefore often "badly" and/or "quickly" done. This can lead to health problems, sometimes very serious. How? Currently, we brush only 1 side of 1 tooth at a time. Our innovation allows us to brush 16 complete teeth simultaneously … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 2 | 0 | 2 | |
HEMARINA Committed to saving lives. Hemarina is an innovative biotechnology company specializing in health product development based in Morlaix (29600, FR). Our search for new solutions based on the properties of the haemoglobin of the arenicola marina worm is permanent to improve the quality of life of patients and their families. Our commitment: to save lives by putting the patient at the heart of all our actions. BioTech, Ocean, Biomimicry, Biology, Biodiversity, and Transplantation Type: Startup Activities: deeptech Technologies: Synthetic Biology | 34 | 19 | 14 | 22 | |
Medsteer Medsteer, with offices in Paris/France (HQ) and New York/USA, is a leading technology provider in the field of closed loop systems for the delivery of anaesthesia drugs. The company’s patented technologies focus on drug delivery solutions guided by the cortical activity of the patient. Medsteer’s proprietary closed loop anesthesia technology (“EasyTIVA”) has been successfully tested in 25 multicenter clinical trials, representing 11 000 patient inclusions, 150 anesthesiologists and 50 operating rooms in Europe since 2003. Providing full automation and customization to the individual patient’s needs, closed loop anaesthesia opens up the way to a wide array of patient benefits associated … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 2 | 0 | 16 | |
Depixus Depixus SAS, based in Paris, is a life science technology company pioneering a groundbreaking technology based on magnetic force spectroscopy. This innovative technology provides real-time analysis of individual biomolecular interactions at scale, enabling researchers to decode disease mechanisms and unlock faster routes to more effective therapies. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 2 | 0 | 63 | |
CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology | 31 | 17 | 23 | 100 | |
NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 9 | |
CELLOMET CELLOMET provides cutting-edge R&D services on cellular metabolism for needs in industry and public institutions. CELLOMET is a spin-off CRO composed of internationally recognized experts in the field of cellular metabolism. Metabolism comprises crucial biological processes which enable breakdown of sugars, proteins, and lipids necessary to provide life-sustaining energy in all types of living organisms. CELLOMET has developed in-depth knowledge and cutting-edge technologies to address any particular metabolic modification occuring at the cellular level. This expertise can be applied to study the effects of pharmacological compounds or natural extracts in cosmetology, the impact of genetic modifications or nutrition, and the … Type: Startup Activities: biotech healthtech deeptech Technologies: Synthetic Biology | 2 | 0 | 1 | 4 | |
Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 13 | 3 | 10 | 14 | |
Carroucell Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade! Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications. Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents. In 2022, … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 2 | 2 | 0 | 5 | |
RESOLUTION Spectra Systems Leader in advanced optical spectroscopy with solutions dedicated to bioprocess Raman monitoring & laser characterization Leader in bioprocess analytical monitoring, RESOLUTION Spectra Systems is now part of Merck PAT, Raman spectroscopy, Chemometrics, Bioprocess, Bioprocess analytics, Cell culture monitoring, Upstream process development monitoring, Process Analytical Technology, Downstream processes control, In-line monitoring, and Real-time monitoring Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 8 | 2 | 8 | 3 | |
Luxia Scientific New generation microbiome diagnostics for personalised medicine Luxia Scientific is a french start-up company, leading the next wave of breakthrough personalized diagnostics. The company was started by Alessandra Cervino, former research director at Enterome. Luxia scientific is pioneering the development of novel diagnostics based on the genetic analysis of microbiomes. The company has brought to the market it’s first test in Q4 2018 and is developing two additional diagnostics. The Company is affiliated to Medicen and is supported by the BPI, Region Ile de France. Statistics, Biomarkers, Statistical genetics, qPCR, genetics, genomics, microbiome, metagenomics, nutrition, well being, health, probiotics, prebiotics, … Type: Startup Activities: biotech deeptech healthtech Technologies: Data Analytics Synthetic Biology | 4 | 3 | 0 | 1 | |
Fizimed A powerful way to women's healthcare A pioneer in FemTech and HealthCare, Fizimed develops innovative, connected medical devices that make it easy to take control of your health at home. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 23 | 12 | 5 | 20 | |
Hilum Healthcare Not your grandpa's Medtech The story of aerospace engineers who aim at building top-notch medical devices. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 16 | 0 | 13 | 11 | |
X-PRESSURE Better measure CSF pressure at bedside X-Pressure est un dispositif médical innovant pour la mesure automatique et instantanée de la pression du liquide cérébro-spinal (LCS). La mesure de pression du LCS est historiquement réalisée par l’étude de la colonne d'eau au bout d’une aiguille de ponction lombaire (PL). Cette mesure est longue, imprécise et ne permet pas de détecter d’éventuelles anomalies. Or, une pression anormale peut avoir des conséquences graves pour le cerveau. X-Pressure développe un nouveau dispositif médical simple et précis pour mesurer la pression du LCS au lit du patient. Grâce à un système simple et connecté, le … Type: Startup Activities: healthtech silvertech deeptech Technologies: A.I. Synthetic Biology | 3 | 1 | 2 | 7 | |
MB Therapeutics 3D printed personalized medicines MB Therapeutics is a pharmaceutical company that offer patient centric solutions to Develop and produce personalized medicines. MB Therapeutics solution is powered by 3D printing, allowing dosage, shape and API customization in GMP environement Pharmaceutical development, Pharmaceutical 3D printing, and Personalized medicines Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 8 | 3 | 6 | 8 | |
Cylaos Médical & Dentaire [Automatic translation follows] The combined experience of additive manufacturing and medical engineering With their wealth of knowledge on 3D printers, imaging and medical regulations, Cylaos and Ennoïa offer a UNIQUE and GLOBAL solution to easily integrate 3D printing in hospitals: Cylaos Médical 3D printing, Medical 3D printing, surgical simulation, Orthosis, Prosthetics, Dental, Medical devices, Templates, and Surgical guide Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
OMEDIT Ile-de-France [Automatic translation follows] The Observatory of Medicines 💊, Medical Devices 💉 and Therapeutic Innovation 🔬🧬 OMEDIT Ile-de-France is a regional support structure in the field of Medicines, Medical Devices and Therapeutic Innovation. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 12 | 1 | 10 | 10 | |
OMéDIT Bretagne [Automatic translation follows] Observatory of Medicines, Medical Devices and Therapeutic Innovation Type: Startup Activities: deeptech Technologies: Synthetic Biology | 4 | 1 | 4 | 7 | |
Dolipharm [Automatic translation follows] Medicine delivery and health assistant to take care of you and your loved ones. Dolipharm supports the new roles of companies in health. Intended for employees, our app includes a medicine/parapharmacy concierge service and regular health checks. It helps spread a health culture in companies thanks to new digital tools. health, technology, internet, pharmacist, patient, medication, prescription drugs, e-health, healthcare, greatplacetowork, company, delivery, and HR Type: Startup Activities: healthtech Technologies: Synthetic Biology | 3 | 0 | 3 | 2 | |
AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies. Our most advanced programs are currently in vivo optimization. We are growing and hiring! Check our career website: https://jobs.lever.co/aqemia.com Discover the roles and … Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: deeptech healthtech Technologies: A.I. Generative A.I. Synthetic Biology | 39 | 21 | 21 | 64 | |
Op2Lysis A New Hope for Hemorrhagic Stroke Op2Lysis develops new treatments for patients suffering from thrombosis at the cerebrovascular level, with an initial focus on the hemorrhagic form of stroke. Indeed, there is no currently approved and available therapeutic solution for these patients. The company develops its game-changing NANOp2Lysis platform, associating a breakthrough vectorisation technology, industrial know-how enabling clinical quality production, and preclinical expertise to propose predictive and translational models, a first in this field. O2L-001, the first product resulting from this technology, will soon enter regulatory toxicology with the aim of applying for clinical trial authorisation in patients in North … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 8 | |
Plantibodies A sustainable delivery platform for oral biologics. Plantibodies is a biotech developing a sustainable platform to produce and deliver oral biologics with increased efficacy and less adverse side effects for the patients. Thanks to molecular farming and synthetic biology, our technology enables to produce humanized monoclonal antibodies within edible plant leaves instead of using animal cells, while drastically reducing carbon footprint, slashing production costs by over 90%, and offering medications with remarkable room temperature stability. By effortless storage and a potential worldwide distribution to treat diseases at home such as cancers, inflammations, metabolic diseases and infections, Plantibodies avoids burdensome intravenous … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 5 | 2 | 4 | 5 | |
METHYS Dx Innovating for cancer patients METHYS Dx develops innovative liquid biopsy tests for non-invasive monitoring of cancer patients. Combining unique proprietary molecular signatures and a disruptive ultrasensitive detection technology, METHYS Dx tests will allow monitoring of tumor evolution, and early detection of relapses, thus improving patient care through better-informed therapeutic decisions. ctDNA, Cancer, Biomarqueurs, circulating tumoral DNA, Liquid biopsy, Precision medicine, and ddPCR Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 21 | 7 | 4 | 14 | |
Meddenovo Drug Design Meddenovo offers a unique blend of AI technologies and molecular modeling to design cyclic peptide therapeutics. **About Meddenovo** Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. **Cyclic Peptides: The Future of Drug Discovery** Cyclic peptides represent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At … Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 3 | 3 | 0 | 4 | |
CELLforCURE by Seqens Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering … Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 4 | 2 | 2 | 57 | |
3-D Matrix EMEA 3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 49 | |
ECHODIA ECHODIA offers a wide range of devices specifically adapted to ENT doctors and other healthcare professsionals ECHODIA is a company created in 2009 specialized in hearing assessment in the fields of otorhinolaryngology and neuroscience. It develops and markets several devices dedicated to auditory measurements, specifically adapted to ENT doctors and other healthcare professionals’ needs (hearing care professionals, school nurses, occupational doctors, hospitals, etc.). ECHODIA offers a wide range of screening and diagnostic devices made in France so that you can perform all your hearing tests. ENT, HEARING, MEDICAL DEVICES, OCCUPATION HEALTH, SCREENING, AUDIOMETRY, ABR, TEOAE, MENIERE DISEASE, OCCUPATIONAL MEDICINE, OTOACOUSTICS … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 6 | |
Biothelis [Automatic translation follows] Predicting respiratory distress BIOTHELIS develops and markets the ENDOMARK H1A medical device to predict the occurrence of severe respiratory distress in patients admitted to intensive care. Applicable to COVID-19 pneumonia, it optimizes patient care and improves prognosis. Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 2 | |
AIS BIOTECH A nature-inspired solution to trap pathogens @AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the @Région Auvergne-Rhône-Alpes, France, incorporated in March 2023 with the objective of developing a new class of sugar-based anti-infective biotherapeutics to fight (re)emerging infectious diseases. Thanks to a Bioengineering plateform based on the expertise of the leading edge academic laboratory @CERMAV (@CNRS, @UGA, Grenoble, France), AIS Biotech aims to develop a pipeline of innovative sugar-based biopharmaceuticals which can prevent or treat infections by mimicking the natural host surface oligosaccharide binding-sites of pathogens. GlycoFlu, our first drug-candidate validated at the … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 18 | 7 | 13 | 5 | |
Healabs [Automatic translation follows] Digital & Therapeutics Native Creator of digital solutions for the therapeutic pathway e-health, Medical telemonitoring, Telemonitoring, Software, and Care pathway Type: Startup Activities: healthtech deeptech Technologies: SaaS Synthetic Biology | 5 | 2 | 4 | 14 | |
Pomega Laboratories New Natural & Ethical Anti Inflammatory Pharmaceutical Products Natural Products with Proven Health Claims For PETS. Pomega develops a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage. Product is developed by skilled pharmacist under drug standards frame First product coming out the pipeline is Ω-344 Product , a patented fruit extract with strong anti inflammatory properties osteoarthritis , anti inflammatory, fruit extract, inflammation, arthritis, biotech, NSAIDs, pain, animal, dogs, pets, wellness, healthcare, petfood, and cats Type: Startup Activities: pettech deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | N/A | |
Oncosema Cancer monitoring made easy 🩸OncosemaTM️ is a purpose-driven company. Our mission is to dramatically improve the management of cancer patients by providing simple and non-invasive tools, to assist oncologists in making the best informed decisions for each patient. 🩸OncosemaTM️ is a deeptech start-up. We operate an exclusive technology targeting cancer-specific biomarkers, allowing the quantification and the isolation of Circulating Tumor Cells (CTC) from most types of cancer. 🩸OncosemaTM️ is focused on providing impactful tests for Oncology. ✔️Non-invasive ✔️Sensitive and specific ✔️Easy-to-use OncosemaTM️ is a registred trade mark of Oncocellex. Cancer, Diagnostic, Circulating Tumor Cells, Immunodiagnostic, Liquid Biopsy, Medical research, Patients … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 10 | 4 | 7 | 5 | |
NH TherAguix Nanomedicine For Precision Radiotherapy NH TherAguix , a Phase 2 biotech company, has developed an innovative nano drug AGuIX® to improve cancer treatment by radiotherapy to treat tumours and metastases. Its pharmacological properties and its mode of action by bio-distribution allow it to act in the heart of tumors and confer it a pan-cancer potential. AGuIX® is currently assessed in 4 Phase II randomized trials in brain metastases using either whole brain radiation therapy (NANORAD2, CHUGA, Grenoble, France) or stereo-radiosurgery (NANOBRAINMETS, Dana Farber Brigham Cancer Center, Boston, USA), in glioblastoma (NANOGBM, multicentric, Clermont Ferrand, France) as well as in pancreatic … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 8 | 7 | 1 | 21 | |
ReACT Therapeutics [Automatic translation follows] Breaking resistance barrier in oncology. ReACT Therapeutics is a French biotech company that works to restore the effectiveness of cancer treatments and improve the quality of care provided to patients. Created in January 2023 in Grenoble, ReACT Therapeutics aims to develop a new class of molecules capable of blocking multiresistance phenomena responsible for therapeutic failures. ➡️ Our mission: Working for and with patients to restore the effectiveness of their cancer treatments and improve the quality of their care. ➡️ Our goal: Developing a new class of molecules capable of blocking multiresistance phenomena in oncology. The result of … Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 24 | 7 | 20 | 2 | |
GAOMA Therapeutics Bioactive Lipids: the Future for Breakthrough Therapeutics GAOMA Therapeutics is a biotech company specialized in the development of lipids derivatives as innovative therapeutic molecules. Lipids are a class of compounds that has been largely under-exploited, whereas it plays a key role in many medical conditions. GAOMA has the ambition to tap into the therapeutic potential of lipids. The company’s first drug candidate, GAO-3-02, is a novel patented active ingredient. It aims to address epilepsy and cognitive disorders, by targeting neuroinflammation and brain plasticity. In various preclinical experiments, GAO-3-02 has thus demonstrated its ability to limit seizures, protect and restore cognitive … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 5 | |
StromaCare Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 2 | 16 | |
Edonia Unlocking microalgae potential Unlocking microalgae potential ● EIT Food Seedbed Incubator (2023 Cohort) ● "Deeptech" certified by French Public Investment Bank (BPI) #microalgae #alternativeprotein Type: Startup Activities: foodtech Technologies: Synthetic Biology | 17 | 9 | 9 | 18 | |
Eomaia [Automatic translation follows] Supporting the donation of colostrum from mother to premature child Eomaia is a start-up created in 2022 that designs a medical device to express colostrum in a hospital environment. Colostrum is an infinitely precious immune concentrate for children born prematurely. Often unable to breastfeed, only manual expression of colostrum allows young mothers to collect this "liquid gold" for their infant. However, subject to many obstacles due to a painful artisanal practice, many premature children are unfortunately deprived of it. Eomaia wishes to facilitate the practice of manual expression of colostrum during the maternity stay by offering a … Type: Startup Activities: healthtech Technologies: Synthetic Biology | 11 | 2 | 10 | 1 | |
LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, and biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 43 | |
Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 49 | |
AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 0 | 1 | 14 | |
Kappa Santé [Automatic translation follows] CRO specializing in real-life data Kappa Santé was born from the desire to provide quality services in the fields of epidemiology, pharmacoepidemiology and interventions in public and digital health. The company was founded at the end of 2002 and is based in Paris Kappa Santé is an independent CRO, member of ENCEPP (European Network of Centers for Pharmacoepidemiology and Pharmacovigilance), AFCRO (French Association of CROs), Oséo Excellence (community of entrepreneurs chosen by Oséo) and the Cap digital competitiveness cluster. We have now participated in over 100 studies in many therapeutic areas Public Health, Pharmacoepidemiology, Medical Devices, Intervention … Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 9 | 4 | 2 | 41 | |
RB3D [Automatic translation follows] We support your efforts at work to reduce the arduousness and risks of MSDs We propose to reduce the risks of MSDs in industry, agriculture and logistics. Our manipulators and exoskeletons are adapted to handling applications, in a large number of industrial sectors. Our cobots and exoskeletons aim to bring you power and endurance to increase your efficiency and carry out your arduous manual tasks without the risks of MSDs. Collaborative robots, Exoskeletons, Improvement of working conditions, ergonomics, anti MSDs, risk prevention, cobots, job analysis, industry, logistics, public works, Viticulture, automobile, and market gardening Type: SMB Activities: it services Technologies: Synthetic Biology | 13 | 7 | 9 | 11 | |
Prestwick Chemical Libraries We design and offer a range of smart chemical libraries to ensure a high hit rate Prestwick Chemical is a French provider of smart libraries. For almost 20 years, the company, founded by Prof. Camille-Georges Wermuth, has provided medicinal chemistry services and screening libraries to accelerate small molecules drug discovery. Prestwick has a large portfolio of smart Libraries designed to ensure maximal chemical diversity, possibly to access new IP while remaining within reach of both low and high throughput screening processes. They are constantly updated and improved. Our clients have reported high quality hit generation rate. The Prestwick Chemical Library®, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 7 | |
efFORMip [Automatic translation follows] www.efformip.com • www.twitter.com/ASS_EFFORMIP efFORMip is an association that works to integrate physical activity into the patient's care pathway. Under the acronym, Equipe pour encourager la FORMe dans l'intérêt du patient, it was created in 2005 under the leadership of Professor Danièle Rivière and Dr. Frédéric Depiesse, where several doctors and sports professionals in Midi-Pyrénées joined forces, convinced of the interest of practicing physical activity in a therapeutic approach. Since 2018, it has been chaired by Dr. Bernard Bros and managed by a board of directors whose members come from both the medical and physical activity fields. Its … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 3 | 0 | 3 | 10 | |
Invacare France [Automatic translation follows] Yes, you can. Invacare® is the leading provider of Home Care Medical Devices. Our Products and Services are recognized for their quality and innovative nature. By listening to the needs of our Customers, we contribute to giving them back independence and autonomy in their daily lives. wheelchair, electric wheelchair, home care, medical bed, senior scooter, oxygen therapy, kuschall, alber, positioning, mobility, aquatec, and rea Type: SMB Activities: transporttech deeptech healthtech consumer services Technologies: Synthetic Biology | 2 | 0 | 1 | 140 | |
Ademtech [Automatic translation follows] Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperse polymer beads (CV<20%), highly magnetic (iron oxide content >70%), calibrated from 100 to 500 nm (+/- 10 nm), offering a high specific surface area (5 to 25 m2/g). These magnetic beads are stable, sensitive and quickly separable under a magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 28 | |
Polyplus now part of Sartorius We power your science Polyplus, now part of Sartorius is a leading upstream solutions provider for advanced biologic and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. Headquartered in Europe, the Polyplus team continues to grow globally with operations in the United States … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 1 | 117 | |
ATLANTIC BONE SCREEN Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteoarticular diseases Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin. Thanks to its high expertise, Atlantic Bone Screen also evaluates biomaterials, either for orthopedic or dental applications. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005 by Ronan LE BOT, CEO of the company, Atlantic Bone Screen puts … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 4 | 24 | |
Solventum Medical Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions Type: SMB Activities: healthtech Technologies: Synthetic Biology | 14 | 2 | 8 | 9 | |
Veterans Village of San Diego Leave No One Behind Veterans Village of San Diego (VVSD) has served all veterans since 1981 and is dedicated to “Leave No One Behind.” With five locations throughout San Diego County, VVSD is the only program of its kind in the United States and is nationally recognized as the leader in serving homeless military veterans. Each year VVSD provides services to more than 3,000 military veterans throughout the County of San Diego. Clinical Treatment, Housing, Employment, Mental Health, Mental Health Care, Homelessness, Fighting Homelessness, Healthcare, Volunteer Work, Volunteers, Counseling, Rehab, Rehabilitation, Job Placement, Job Skills, Life Skills, Veterans, Helping Veterans, … Type: SMB Activities: military edtech Technologies: Synthetic Biology | 6 | 0 | 6 | 140 | |
Mibelle Biochemistry Inspired by nature - realized by science 🍏 Inspired by nature – Realized by science Designing ideas for added value In the fast-moving cosmetic industry, innovation is the most important factor as it enables us to deliver new claims, new efficacy tests, new applications, new biochemical findings, as well as new marketing and communication tools to effectively differentiate products. At Mibelle Biochemistry, our mission is to design the most innovative actives for our customers. Inspired by nature – realized by science Our scientists transform naturally derived plant compounds into truly functional bioactive cosmetic ingredients. Our R&D team makes use of … Type: SMB Activities: cosmetics deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 81 | |
Oxford Drug Design A drug-discovery company focused on oncology. Follow us on Twitter @OxDrugDes Oxford Drug Design, an advanced spinout from Oxford University, is an innovative biotechnology company discovering and developing novel therapeutics supported by pioneering computational methods. We design innovative drugs with differentiated modes of action against cancer and other challenging diseases with high unmet medical need seeking superior patient outcomes. Based on the unique integration of our dual core competences in aminoacyl-tRNA synthetase enzymes and distinctive AI/ML methods, our pipeline expansion is focused on oncology. This distinctive drug discovery platform has been validated by the rapid discovery of novel therapeutic candidates … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology A.I. - Machine Learning A.I. | 4 | 1 | 2 | 10 | |
Synairgen plc We are a specialist respiratory biotech company focused on severe viral lung infections Synairgen is a specialist respiratory biotech company whose primary focus is developing its investigative inhaled IFN-β candidate for the treatment of severe viral lung infections as potentially the first host-targeted broad-spectrum antiviral treatment delivered directly into the lungs. Founded by University of Southampton (UK) Professors Sir Stephen Holgate, Donna Davies and Ratko Djukanovic in 2003, Synairgen is quoted on AIM (LSE: SNG). For more information, please visit www.synairgen.com. Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 1 | 29 | |
Source BioScience Industry-leading provider of Genomic and Histopathology services, including Cellular & Digital Pathology. Source BioScience, comprised of Source LDPath and Source Genomics, provides industry-leading laboratory services in Genomics and Histopathology, partnering with biotechnology, pharmaceutical, healthcare and academia. Source LDPath provides an end-to-end clinical diagnostic service, from histopathology, including digital pathology and AI, through to molecular diagnostic services. Source LDPath already supports over 85 NHS Trusts and a comprehensive network of Private Healthcare clinics to expand their diagnostic capabilities, ensuring diagnostic results are delivered within clinically actionable timeframes. Source LDPath brings pioneering expertise in digital pathology and AI implementation, helping NHS pathology … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 0 | 5 | 193 | |
MedicAlert Foundation - United States Saving lives since 1956. Original creator of the medical ID and 24/7 emergency response service. 501(c)(3) nonprofit. Established in 1956, the nonprofit MedicAlert Foundation pioneered the use of medical IDs and delivers the most dependable, responsive, and trusted Emergency Identification and Medical Information Network. MedicAlert provides the functionality of an e-health information exchange through an innovative combination of a unique patient identifier linked to a personal health record and a live 24/7 U.S.-based emergency response service. MedicAlert Foundation medical IDs alert emergency personnel to a member’s primary health conditions, medications or implanted medical devices. In addition to its 24-hour emergency … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 80 | |
Laboratoires Vivacy Laboratories VIVACY is a French manufacturer specialising in the design, production and distribution of high quality injectable medical devices for use in the field of Anti-ageing, especially in Medical Aesthetics and Viscosupplementation. Founded in 2007 by specialists qualified in biopolymers and injectable product technologies with more than 25 years’ experience in the field, the company has acquired recognised expertise in dermal fillers based on hyaluronic acid and natural antioxidants, mannitol and sorbitol. The company has also created new technologies for use in ophthalmology (I.SPACE®), rheumatology (KARTILAGE®), gynecology (DESIRIAL®) and is currently developing in other medical viscosupplementation fields. Thanks to its … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 278 | |
Chiesi France [Automatic translation follows] Taking care of patients and the planet today for tomorrow! CHIESI is an Italian family biopharmaceutical group offering innovative therapeutic solutions to patients in 3 therapeutic areas: AIR (products and solutions for respiratory diseases from newborns to adults), RARE (treatments for rare and ultra-rare diseases), CARE (products and services in kidney and liver transplantation and prevention, in micronutrition) With nearly 6,500 employees worldwide, CHIESI is present in France across the entire value-added chain - R&D, production, distribution and provision to healthcare professionals and patients - with a turnover reaching nearly €175 million in 2022. Certified B-Corp, CHIESI … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 8 | 3 | 5 | 341 | |
Airnov Healthcare Packaging Protecting Today, Preserving Tomorrow Protecting Today, Preserving Tomorrow. Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 126 | |
Fedmind [Automatic translation follows] Nourish your mind. *Closed company* Fedmind is a health application for therapeutic education of overweight or obese patients. A player in the field of prevention and medical research, Fedmind works to offer a different, complementary and comprehensive treatment of the disease. The application offers a complete one-year program with online therapy to work on the causes of obesity, education on balanced nutrition and physical activity circuits adapted to overweight people. With the help of a caring community through weekly support groups, monitoring by the care team via the application and FedAlert', a tool to disarm eating crises … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 4 | 1 | 1 | 2 | |
BioPharmGuy Worldwide Biotech Company Database BioPharmGuy is a website that functions as a directory of companies in the biotechnology, pharmaceutical, medical device & life science industries. We offer services for businesses as well as job seekers. The site is constantly being updated to ensure we have the most accurate and high quality, free-to-use database. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Rapid Release Therapy Innovator of targeted, high speed vibration technology for professionals focused on musculoskeletal health & wellness. Rapid Release Technology is a commercial grade vibration therapy used by professional athletes and practitioners for fast pain relief. Unlike percussive devices (massage guns), vibration therapy may be used on areas percussive therapy cannot treat, such as the cranial, spinal column, TMJ, bony prominences and tendons. Our latest innovation, the Rapid Release PRO3 is the new flagship device. It has been engineered and refined to make it lighter, smoother, quieter, and best of all, cordless with a long battery life. health & wellness, chiropractors, physical … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 13 | |
Amparo Revolutionizing Prosthetics Amparo is redesigning prosthetic care to enhance the experience for amputees & orthopaedic technicians. With over 4500 patients fitted in 5 continents, Amparo products are present in over 200 clinics worldwide. We believe that prostheses for recent amputees can be improved to help people with a faster physical and psychological recovery. Prosthetics, Medical Engineering, Amputees, Social Entrepreneurship, Innovation, Design Thinking, Medtech, Assistive Devices, Worldwide, O&P, and Health Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology | 6 | 1 | 5 | 9 | |
UTI-lizer Revolutionizes the Urinary Tract Infection diagnostics! Urinary tract infections (UTIs) are the most common bacterial infections in women. More than half of all women suffer at least once from a UTI. Current over-the-counter tests are not sensitive enough, and diagnosis of UTI is today based on symptoms only, leading to non-optimal treatment and unnecessary use of antibiotics. We have miniaturized culture-based bacterial detection (gold standard for UTI diagnosis) in a dipstick format with a highly sensitive and quantitative digital bioassay. We can detect and quantify bacteria in the clinically relevant range, without any complicated lab instruments, and with a readout … Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 10 | |
Nextkidney Dialysis Anytime, Anywhere. NextKidney’s mission is to develop and commercialize the Neokidney home hemodialysis device. Placing the patient and his quality of life at the center of its approach, the company uses innovative technologies to offer a safe, practical and easy-to-use solution as quickly and widely as possible throughout the world. medical device, Manufacturing , Dialysis, and Home Dialysis Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 47 | |
Ousia Pharma Danish biotech company developing peptide-small molecule drugs for treatment of obesity Ousia Pharma is a biotech spin-out from the University of Copenhagen developing novel peptide-drug conjugates for treatment of obesity and metabolic diseases. The company uses a proprietary targeting approach in which peptides are used to deliver modulators of synaptic plasticity to drive a potent and sustained weight loss without compromising safety. A main objective of Ousia Pharma is to advance the development of the lead weight loss drug candidate (OP-56) within general obesity. Type: Startup Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
Circio Holding ASA Developing novel circular RNA and immunotherapy medicines. Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 20 | |
iPC H2020 Giving clinicians the tools and knowledge to create individualized treatment plans for their paediatric cancer patients. Cancer in children is rare but when it happens, clinician prescribed treatment options are not always as clear as one would hope. In fact, on average, only a quarter of oncology patients respond to the drug therapy they receive. There are many reasons for this but evidence shows that a personalized treatment plan or treatment that is based on the patient's fundamental biology could significantly enhance treatment outcomes. As it turns out, the personalized treatment plan can be as complex as the cancer itself … Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 0 | |
Nimbus Therapeutics Applying deep computational chemistry expertise to create novel small molecule therapeutics. At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. With a decade-plus track record of success, we’ve built a world-class team in both computationally driven drug discovery and early clinical development while continuing to move the needle for patients. computational chemistry, biochemistry, small molecule therapeutics, oncology, immunology, metabolism, and drug … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 6 | 104 | |
ApconiX Nonclinical safety experts asking the right questions at the right time to make safer, more effective drugs ApconiX was formed by three AstraZeneca colleagues with the drive and ambition to create a world-renowned company known for its expertise in nonclinical safety toxicology and ion channel electrophysiology. The company is founded on the skills and experience of a growing team with a wide range of expertise in preclinical drug safety. The model for the pharmaceutical industry has evolved in recent years with large pharma reducing internal capability and outsourcing key skills to trusted partners. There are many more SMEs who also … Type: Startup Activities: biotech Technologies: Synthetic Biology | 7 | 0 | 7 | 57 | |
Sense4Care We design, develop and produce wearables and medical devices based on the identification of human movement patterns Sense4Care is a company specialized in the design and manufacture of medical devices, which aims to improve the quality of life of people. Based in Barcelona area, is formed by a high qualified team that come from the fields of engineering, medicine and business. The company develops and markets cutting-edge solutions based on the knowledge generated by the Universitat Politècnica de Catalunya (UPC) in research projects mainly related to fall detection and Parkinson’s disease, among others. ehealth, technology, medical, parkinson, and fall detection Type: Startup Activities: silvertech deeptech healthtech manufacturing Technologies: Synthetic Biology | 5 | 0 | 0 | 10 | |
EKPO Fuel Cell Technologies GmbH The future mobility – already in series production today. EKPO Fuel Cell Technologies is a leading joint venture in the field of development and large-scale production of fuel cell stacks for CO2-neutral mobility. We are a full-service supplier for fuel cell stacks and components used in trucks, buses, light commercial vehicles, but also SUVs and larger passenger cars and for rail and marine applications. We build on the industrialization expertise of the two established international automotive suppliers ElringKlinger and Plastic Omnium. Type: Startup Activities: energytech transporttech Technologies: Synthetic Biology | 2 | 1 | 2 | 136 | |
TSC Connected Care Turnkey Digital Health Solutions TURNKEY SOLUTIONS TSC Connected Care provides turnkey solutions to help free up beds and staff to deliver more and better patient care! Sensium, our ICU grade wireless monitoring technology, has been shown to reduce Length of Stay by 10-30%. Thelma, our smart medication dispenser, can free up to 66% of home care workforces. Vital signs monitoring, Wireless medical devices, and Ultra-low power wireless technologies Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 2 | 35 | |
RoslinCT Your Advanced Cell & Gene Therapy CDMO Partner RoslinCT is a leading global contract development and manufacturing services organization (CDMO) focused on Advanced Cell and Gene Therapies. Established in 2006 and built upon the groundbreaking technology cloning of Dolly the Sheep at the Roslin Institute in 1997, RoslinCT has harnessed cutting-edge science to advance the development of human medicines. With a remarkable heritage in the field, the company has achieved significant milestones, including being among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR-edited stem cell-based therapy for a major disease to … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 339 | |
Krystal Biotech, Inc. A commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines for high unmet medical needs. Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 0 | 2 | 261 | |
Microsynbiotix, Ltd. A Sundew company We are creating a potentially revolutionary algal platform technology. Thanks to major advances in algal genomics and molecular biology, microalgae can be engineered to express inexpensive therapeutic proteins and vaccines of economic value. The cost of the synthetic biology tools has dropped. We are building our technology based on solid, peer-reviewed science[1][2][3][4]. By using microalgae as an oral delivery vehicle, we can substantially cut the labor and post-processing production costs, allowing us to produce effective vaccines that are much more affordable and user-friendly. Our technology can reduce or eliminate the use of antibiotics, reduce fish mortality rates … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 1 | 2 | 36 | |
Mursla Bio Pushing the boundaries of biopsy technology Mursla Bio is a pioneering biotech company on a mission to transform cancer care by pushing the boundaries of biopsy technology. Its breakthrough dynamic biopsy platform combines the strengths of both tissue and liquid biopsies without their limitations in invasiness or biological insights. Dynamic biopsy is made possible by coupling the latest of extracellular vesicle (EV) and extracellular omics science with Mursla Bio’s pioneering EV technologies. Mursla Bio’s initial focus is to transform the surveillance of liver cancer in high-risk populations - the fastest growing cause of cancer related deaths. Mursla Bio is currently … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 15 | |
Inspire Medical Systems We are committed to elevating and redefining the standard of care for Obstructive Sleep Apnea. Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Obstructive Sleep Apnea, ENT, sleep, patient engagement, digital health, medical device, medical devices, Sleep Apnea, Healthcare, … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 2 | 1,169 | |
OrthoHeal Healing Comfortably ! OrthoHeal is the leading Medical Technology (Med-Tech) company that specializes in the orthopedic medical devices. We relentlessly strive to intensively research and innovate technologies by discovering newer horizons of potential solutions for improving patient-care and state-of-the-healthcare. We specifically emphasize on improving the experience for post-operative orthopedic recoveries while also discovering, inventing and enhancing the potentials for comfort and convenience in healthcare. Leveraging our knowledge and technology OrthoHeal has flourished as a company with several innovative products with disruptive technologies under the brand-name FlexiOH®. FlexiOH® is the next generation orthopedic immobilization technology invented, developed, patented and delivered world-wide … Type: Startup Activities: healthtech deeptech martech Technologies: New Materials Synthetic Biology | 1 | 0 | 0 | 58 | |
CITO Medical New Product Development of Medical Devices & Biotech Instruments CITO Medical is an engineering firm specializing in new product development of medical devices, life science lab equipment, point of care diagnostic instruments and microfluidic cartridges. CITO partners with technology startups, Fortune 500 companies and academic institutions to bring product and research ideas to life through precision engineering, innovative hardware and solution-driven design and development. A unique blend of engineering principles and modern design techniques enable our engineers to turn your ideas into working products and solutions that transform everyday life around the world. Core capabilities include: Mechanical Engineering, Electrical Engineering, … Type: Startup Activities: healthtech deeptech biotech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
AbiliLife Join us on our mission to reduce back injuries and create a safer workforce with the Calibrace+ back brace. AbiliLife is a leading medical technology company transforming how people manage their mobility and balance challenges. Our innovative products are designed to enhance the quality of life and empower individuals to live independently and pain-free. Our flagship product, the Calibrace+, is a unique back brace that provides targeted support to the trunk and helps improve posture and balance. The Calibrace+ is a game-changer for workforces. Back injuries and pain are common problems in many industries, reducing productivity, absenteeism, and healthcare costs. … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
Diagante Unlocking the potential of solid samples in the field of biological diagnostic Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 19 | 7 | 9 | 7 | |
StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 14 | 10 | 3 | 4 | |
Systol Dynamics Bridge-to-recovery by design Systol Dynamics designs and develops an innovative Ventricular Assist Device (VAD) that extends the benefits of mechanical circulatory support to less severe heart failure patients. Uniquely positioned in the aorta by transcatheter implantation, the Systol Dynamics’s VAD is at one minimally-invasive, connected and removable. Unlike terminal solutions, bridge to transplant or destination therapy, it relieves the patient’s heart and enables physiological recovery, ultimately leading to cardiac pump removal. Founded in 2018 by a cardiologist with more than 30 years of experience in the management of cardiac insufficiency, Systol Dynamics is managed by a team of experts in … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 4 | |
Tafalgie Therapeutics [Automatic translation follows] Research contributing to health and well-being: innovative polypeptides for the prevention & treatment of pain Tafalgie Therapeutics is a spin-off company of CNRS and AMU engaged in biopharmaceutical research and committed to the development of a new scientific approach for next-generation treatments based on a breakthrough innovation: a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals. Tafalgie Therapeutics aims to become the leading player in the field of pain, by designing and proposing new pharmaceutical active ingredients based on the development of polypeptides derived from TAFA4. At Tafalgie Therapeutics, we aim … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 33 | 10 | 9 | 15 | |
ExAdEx-Innov Beyond fat cells, the Real Human Fat Tissue Unique R&D platform of donor-derived real human adipose tissue ex vivo for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology from French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 9 | 12 | 6 | |
REALETEE [Automatic translation follows] Custom external breast prosthesis. 3D medical device to replace the breast identically after breast cancer Custom external breast prosthesis. breast prosthesis, external prosthesis after breast cancer, 3D scan, 3D printing, and CAD Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 1 | |
ECLEVAR Your smart way to compliance As a CRO, we help our customers provide patients with safe and effective medical devices through solutions tailored to their business and regulatory challenges. OUR VALUES Trust and quality are the hallmarks of the way we work and partner with our clients. OUR MISSION We help our clients provide patients with safe and effective medical devices. OUR VISION Cost effectiveness, time savings and management of regulatory constraints. Regulatory evolutions differ from one region to another: they have their own rules and requirements for medical devices. It is crucial to partner with a CRO that understands … Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 35 | |
NeoVentures Biotechnology Europe Aptamarker Platform | High-Plex Proteomics | Biomarker Discovery | Advanced DNA Aptamer Library & Machine Learning At NeoVentures Biotechnology Europe we are committed to revolutionizing the biopharmaceutical field through a cutting-edge biomarker discovery platform, propelling the industry towards personalized medicine with rapid, cost-effective, and automated processes for biomarker discovery and validation. Our Aptamarker platform leverages a library of 16.8 million DNA aptamers to analyze epitope profiles in biofluids, liquid biopsy or tissue, facilitating the precise measurement of surrogate biomarkers and expediting the creation of predictive In Vitro Diagnostic (IVD) tests tailored to distinct pathophysiological conditions. With our advanced DNA aptamer … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 4 |